Endogenous angiotensin II produced by endothelium regulates interleukin- 1β-stimulated nitric oxide generation in rat isolated vessels

Hypertension

Volumn 30, Issue 5, 1997, Pages 1191-1197

  Montón, Mercedes ^a   López Farré, Antonio ^a   Mosquera, Juan R ^a   De Miguel, Lourdes Sánchez ^a   García Durán, Margarita ^a   Sierra, María P ^a   Bellver, Teresa ^a   Rico, Luis ^a   Casado, Santos ^a  

^a Hospital U   (Spain)

Author keywords

Angiotensin II; Aorta; Endothelium; Endothelium derived factors

Indexed keywords

ANGIOTENSIN; ANGIOTENSIN 1 RECEPTOR ANTAGONIST; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; FOSINOPRIL; INTERLEUKIN 1BETA; LOSARTAN; NITRIC OXIDE; NITRIC OXIDE SYNTHASE; NITRITE;

ADOLESCENT; ANIMAL TISSUE; AORTA; ARTICLE; BLOOD VESSEL WALL; CONTROLLED STUDY; ENZYME INDUCTION; ENZYME INHIBITION; MALE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; RAT; VASCULAR ENDOTHELIUM;

EID: 18844465536     PISSN: 0194911X     EISSN: None     Source Type: Journal    
DOI: 10.1161/01.HYP.30.5.1191     Document Type: Article

References (31)

1. Dzau VJ, Gibbons GH. Cell biology of vascular hypertrophy in systemic hypertension. Am J Cardiol. 1988;62:30G-35G.
2. Lilly LS, Pratt RE, Alexander RW, Larson DM, Ellison KE, Gimbrone MA, Dzau VJ. Renin expression by vascular endotheliat cells in culture. Circ Res. 1985;57:312-318.
3. Shaw-Yung S, Fishel RS, Martin BM, Bradford CB, Bernstein KE. Bovine angiotensin converting enzyme cDNA cloning and regulation. Increased expression during endothelial cell growth arrest. Circ Res. 1992;70:1274-1281.
4. Moncada S, Palmer RMJ, Higgs A. Nitric oxide: physiology, pathophysiology and pharmacology. Pharmacol Rev. 1991;43:109-141.
5. Radomski MW, Moncada S. Regulation of vascular homeostasis by nitric oxide. Thromb Haemost. 1993;70:36-41.
6. Lopez-Farré A, Caramejo C, Esteban A, Alberola ML, Millás I, Monton M, Casado S. Effects of aspirin on platelet-neutrophil interactions. Role of nitric oxide and endothelin-1. Circulation. 1995;91:2080-2088.
7. May GR, Crook P, Moore PK, Page CP. The roie of nitric oxide as an endogenous regulator of platelet and neutrophil activation within the pulmonary circulation of the rabbit. Br J Pharmacol. 1991;102:759-763.
8. Trachtman H, Futterweit S, Singhal P. Nitric oxide modulates the synthesis of extracellular matrix proteins in cultured rat mesangial cells. Biochem Biophys Res Commun. 1995;207:120-125.
9. Moncada S, Higgs A. The L-arginine-nitric oxide pathway. N Engl J Med. 1993;329:2002-2012.
10. Schini VB, Junquero DC, Scott-Burden T, Vanhoutte PM. Interleukin-1β induces the production of an L-arginine-derived relaxing factor from cultured smooth muscle cells from rat aorta. Biochem Biophys Res Commun. 1991;176:114-121.
11. Nakayama I, Kawahara Y, Tsuda T, Okuda M, Yokoyama M. Angiotensin II inhibits cytokine-stimulated inducible nitric oxide synthase expression in vascular smooth muscle cells, J Biol Chem. 1994;269:11628-11633.
12. Joly GA, Schini VB, Vanhoutte PM, Balloon injury and interleukin 1-β induce nitric oxide synthase activity in rat carotid arteries. Circ Res. 1992;71:331-338.
13. López Farré A, Mosquera JR, Sánchez de Miguel L, Millás I, de Frutos T, Montón M, Sierra MP, Riesco A, Casado S, Endothelial cells inhibit nitric oxide generation by vascular smooth muscle cells: role of transforming growth factor-β. Arterioscler Thromb Vasc Biol. 1996;16:1263-1268.
14. Laemmli NK. Change of structural proteins during the assembly of the head of bacteriophage T4. Nature. 1970;227:680-685.
15. McGuire PG, Orkin RW. Isolation of rat aortic endothelial cells by primary explant techniques and their phenotypic modulation by defined substrates. Lab Invest. 1987;57:94-104.
16. Murray BM, Paller MS. Decreased pressor reactivity to angiotensin II in cirrhotic rats. Evidence for a post-receptor defect in angiotensin action. Circ Res. 1985;57;424-431.
17. Timmermans PBMWM, Wong PC, Chin AT, Herblin WF, Benfield P, Corini DJ, Lee RJ, Wexler RR, Saye JAM, Smith RD. Angiotensin II receptors and angiotensin II receptor antagonists. Pharmacological Rev. 1993;45:205-251.
18. + antiporter in vascular smooth muscle cells in culture. Kidney Int. 1994;45:66-75.
19. Cahill P, Redmond E, Foster C, Sitzmann JV. Nitric oxide regulates angiotensin II receptors in vascular smooth muscle cells. Eur J Pharmacol. 1995;288:219-222.
20. Fleming I, Gray G, Stoclet JC. Influence of endothelium on induction of the L-arginine-nitric oxide pathway in rat aortas. Am J Physiol. 1993;264:H1200-H1207.
21. Chandler LJ, Kopnisky K, Richards E, Crews FT, Summers C. Angiotensin II decreases inducible nitric oxide synthase expression in rat astroglial cultures. Am J Physiol. 1995;268:C700-C707.
22. Kifor I, Dzau VJ, Endothelial renin-angiotensin pathway: evidence for intracellular synthesis and secretion of angiotensins. Circ Res. 1987;60:422-428.
23. Stoll M, Steckelings UM, Paul M, Bottari SP, Metzger R, Unger T, The angiotensin AT-2 receptor mediates inhibition of cell proliferation in coronary endothelial cells. J Clin Invest. 1995;95:651-657.
24. Burnier M, Centeno G, Waeber G, Centeno C, Bürki E. Effect of endotoxin on the angiotensin II receptor in cultured vascular smooth muscle cells. Br J Pharmacol. 1995;116:2524-2530.
25. Kauffman RF, Bean JS, Zimmerrnan KM, Brown RF, Steinherg MI. Losartan, a nonpeptide angiotensin II (Ang II) receptor antagonist, inhibits neointima formation following balloon injury to rat carotid arteries. Life Sci. 1991;49:PL223-PL228.
26. Osterrieder W, Müller RKM, Powell JS, Clozed JP, Hefti F, Baumgartner HR. Role of angiotensin II in injury-induced neointima formation in rats. Hypertension. 1991;18:II-60-II-64.
27. Rakugi H, Kim DK, Krieger JE, Wang DS, Dzau VJ, Pratt RE. Induction of angiotensin converting enzyme in the neointima after vascular injury. Possible role in restenosis. J Clin Invest. 1994;93: 339-346.
28. Linz W, Wiemer G, Gohlke P, Unger T, Schólkens BA. Contributions of kinins to the cardiovascular actions of angiotensin-converting enzyme inhibitors. Pharmacol Rev. 1995;47:25-49.
29. Dusting GJ, Hyland R, Hickey H, Makdissi M. Angiotensin-converting enzyme inhibitors reduce neointimal thickening and maintain endothelial nitric oxide function in rabbit carotid arteries. Am J Cardiol. 1995;76:24E-27E.
30. Farhy RD, Carretero OA, KLH, Scichi G, Role of kinins and nitric oxide in the effects of angiotensin converting enzyme inhibitors on neointima formation. Circ Res. 1993;72:1202-1210.
31. Tiffany CW, Burch RM. Bradykinin stimulates tumor necrosis factor and interleukin-1 release from macrophages. FEBS Lett. 1989;247:192.